Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Mahamaya Lifesciences Limited	3.8	3.8	17.95		21.16		Consolidated
Nova Agritech Limited	4.2	4.2	21.45	15.14	14.64	2.38	Consolidated
Bhagiradha Chemicals & Industries Ltd.	1.75	1.61	397.59	169.65	4.46	4.06	Consolidated

Notes:

P/E figures for the peer are based on closing market prices of equity shares on BSE on January 08, 2025 divided by the Basic EPS as at March 31, 2024.
Basic and Diluted EPS refers to the Basic and Diluted EPS sourced from the Annual Report for the FY 2023-24 of the listed peer company.
Return on Net Worth (%) for listed peer companies has been computed based on the Net Profit After Tax for the year ended March 31, 2024 divided by Total Equity as on March 31, 2024.
NAV per share for listed peer companies is computed as the networth as on March 31, 2024 divided by the outstanding number of equity shares as on March 31, 2024

Mahamaya Lifesciences IPO Review by Members

Mahamaya Lifesciences IPO Reviews, analysis and views by popular members. Read Mahamaya Lifesciences Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Mahamaya Lifesciences IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Useful Articles